ABSTRACT
PURPOSE: To analyze the clinical pattern of ocular toxoplasmosis (OT) in a referral centre in Serbia. PATIENTS AND METHODS: The medical records of consecutive patients admitted for OT to the single referral centre for uveitis in Serbia between 2006 and 2010 were retrospectively analyzed. OT was diagnosed on the basis of typical fundus lesions and positive serology for Toxoplasma. RESULTS: In a total of 457 uveitis patients, OT was the third leading cause, with 59 patients (12.9%). Most OT cases (73%) were monocular. An active primary retinal lesion was observed in 36% and recurrent OT in 64% patients. Localization of lesions was central/paracentral (44%), juxtapapillar (27%), peripheral (19%), and multifocal (10%). Other ocular manifestations of inflammation included vitritis (44%), anterior uveitis (19%), and retinal vasculitis (10%). Complications included choroidal neovascularization in two and exudative retinal detachment with cataract, glaucoma, and cystoid macular oedema in one patient each. The detection of Toxoplasma-specific IgM antibodies in a single patient indicates a low rate of OT concomitant with acute infection. After treatment, the mean best-corrected visual acuity (BCVA) increased significantly. However, 14 (24%) patients ended up legally blind in the affected eye, of which 2 (3%) with bilateral blindness, all with a very poor BCVA (0.047 ± 0.055) at presentation. Visual impairment and treatment outcome were both associated with central localization of lesions (P<0.0001 and P=0.006, respectively). CONCLUSION: OT is a significant cause of posterior uveitis in Serbia. Patients should be aware of the recurring nature of OT and react immediately if symptoms occur.
Subject(s)
Toxoplasmosis, Ocular/epidemiology , Adult , Antibodies, Protozoan/blood , Antiprotozoal Agents/therapeutic use , Choroidal Neovascularization/epidemiology , Choroidal Neovascularization/immunology , Choroidal Neovascularization/parasitology , Enzyme-Linked Immunosorbent Assay , Female , Fluorescein Angiography , Glaucoma/epidemiology , Glaucoma/immunology , Glaucoma/parasitology , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Middle Aged , Referral and Consultation , Retinal Detachment/epidemiology , Retinal Detachment/immunology , Retinal Detachment/parasitology , Retrospective Studies , Serbia/epidemiology , Tomography, Optical Coherence , Toxoplasma/immunology , Toxoplasmosis, Ocular/immunology , Toxoplasmosis, Ocular/parasitology , Uveitis/epidemiology , Uveitis/immunology , Uveitis/parasitology , Visual Acuity/physiologySubject(s)
Antibodies, Monoclonal/therapeutic use , Antiprotozoal Agents/therapeutic use , Choroidal Neovascularization/drug therapy , Retinal Hemorrhage/drug therapy , Toxoplasmosis, Ocular/drug therapy , Adult , Antibodies, Monoclonal, Humanized , Child , Choroidal Neovascularization/diagnosis , Choroidal Neovascularization/parasitology , Drug Therapy, Combination , Fluorescein Angiography , Humans , Injections , Leucovorin/therapeutic use , Male , Pyrimethamine/therapeutic use , Ranibizumab , Retinal Hemorrhage/diagnosis , Retinal Hemorrhage/parasitology , Sulfadiazine/therapeutic use , Tomography, Optical Coherence , Toxoplasmosis, Ocular/diagnosis , Toxoplasmosis, Ocular/parasitology , Visual Acuity , Vitreous BodySubject(s)
Choroidal Neovascularization/parasitology , Eye Infections, Parasitic/parasitology , Retinal Diseases/parasitology , Adult , Choroidal Neovascularization/diagnosis , Choroidal Neovascularization/drug therapy , Drug Therapy, Combination , Eye Infections, Parasitic/diagnosis , Eye Infections, Parasitic/drug therapy , Female , Fluorescein Angiography , Glucocorticoids/therapeutic use , Humans , Photochemotherapy , Photosensitizing Agents/therapeutic use , Porphyrins/therapeutic use , Retinal Diseases/diagnosis , Retinal Diseases/drug therapy , Tomography, Optical Coherence , Triamcinolone Acetonide/therapeutic use , Verteporfin , Visual AcuityABSTRACT
PURPOSE: To evaluate the efficacy and safety of verteporfin photodynamic therapy (V-PDT) for young adults and children with subfoveal choroidal neovascularization (CNV) associated with toxoplasmic retinochoroiditis. METHODS: Patients with subfoveal CNV associated with toxoplasmic retinochoroiditis were treated with V-PDT and prospectively followed up. Before V-PDT and during follow-up, patients underwent visual acuity testing, complete ophthalmic examination including color photography, angiography with fluorescein and/or indocyanine green, and optical coherence tomography. The decision to retreat CNV was based on the criteria used in the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy investigation. RESULTS: Eight patients (5 males and 3 females) were treated at a mean age of 15.3 years (range, 5-31 years). CNV was 100% classic or predominantly classic in all study patients. Mean visual acuity increased from 20/225 (range, 20/400 to 20/50) to 20/123 (range, 20/200 to 20/25) during a mean follow-up period of 25 months (range, 5-49 months). Persistent closure of CNV was achieved in all eight patients (mean number of treatments, 1.75). Vascular anastomosis developed in the treated area in two patients, but there was no additional visual loss. No significant adverse effects of V-PDT were observed. CONCLUSION: V-PDT for subfoveal CNV associated with toxoplasmic retinochoroiditis appears to be effective and safe even in young adults and children. However, a longer follow-up is recommended to confirm our observations.
Subject(s)
Chorioretinitis/drug therapy , Choroidal Neovascularization/drug therapy , Photochemotherapy , Photosensitizing Agents/therapeutic use , Porphyrins/therapeutic use , Toxoplasmosis, Ocular/complications , Adolescent , Adult , Antibodies, Protozoan/blood , Child , Child, Preschool , Chorioretinitis/diagnosis , Chorioretinitis/parasitology , Choroidal Neovascularization/diagnosis , Choroidal Neovascularization/parasitology , Coloring Agents , Enzyme-Linked Immunosorbent Assay , Female , Fluorescein Angiography , Humans , Indocyanine Green , Male , Photosensitizing Agents/adverse effects , Porphyrins/adverse effects , Retrospective Studies , Tomography, Optical Coherence , Treatment Outcome , Verteporfin , Visual AcuitySubject(s)
Choroidal Neovascularization/diagnosis , Retinal Diseases/diagnosis , Toxoplasmosis, Ocular/diagnosis , Adult , Animals , Antibodies, Protozoan/blood , Choroidal Neovascularization/drug therapy , Choroidal Neovascularization/parasitology , Enzyme-Linked Immunosorbent Assay , Fluorescein Angiography , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Retinal Diseases/drug therapy , Retinal Diseases/parasitology , Spiramycin/analogs & derivatives , Spiramycin/therapeutic use , Toxoplasma/immunology , Toxoplasmosis, Ocular/drug therapy , Toxoplasmosis, Ocular/parasitologyABSTRACT
BACKGROUND: Ocular toxocariasis is a rare infection caused by the nematode larvae of toxocara canis, which is commonly found in dogs. Human transmission is usually via geophagia, the ingestion of food contaminated with the toxocara eggs, or contact with infected puppies, often resulting in devastating ocular and/or systemic effects. Distribution is worldwide; however, a higher incidence is demonstrated in the United States. METHODS: A 17-year-old black woman sought treatment at a neighborhood health center with a report of gradual decrease in vision from her left eye over a 3-month period. Her ocular and systemic histories were unremarkable. Anterior segment evaluation revealed no signs of anterior uveitis. The posterior pole showed a 1.5 DD, round, raised, white, subretinal lesion adjacent to the fovea with an overlying serous retinal detachment and retinal hemorrhage. RESULTS: She was referred to a retinologist who performed both fluorescein and indocyanine green (ICG) angiographies. A serum toxocara ELISA test was also ordered. Fluorescein angiography revealed hyperfluorescence consistent with the granuloma. The ICG demonstrated an occult choroidal neovascular membrane (CNV) underlying the area of hemorrhage inferotemporal to the granuloma. CONCLUSION: This paper illustrates the case presentation and includes an extensive review of the ocular and systemic manifestations of toxocariases. A description of ICG videoangiography, therapeutic approaches, and management will also be discussed.